A Pharmacodynamic and Safety Study of BCS in Healthy Volunteers

NCT02594449 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-11-03

No results posted yet for this study

Summary

To compare pharmacodynamics among the different concentrations of BCS and NS.

Conditions

  • Healthy Volunteers

Interventions

DRUG

Benzalkonium Chloride Solution

To compare pharmacodynamics among the different concentrations of BCS and NS

Sponsors & Collaborators

  • Lustre Pharmaceutical Lab Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Shiyue Li, Professor · The First Affiliated Hospital of Guangzhou Medical University

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-01-31
Completion
2016-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02594449 on ClinicalTrials.gov